证券记录 · 已归档季度
EXEL
Exelixis, Inc. · Healthcare · Biotechnology
15被追踪持有人
+1Δ持有人
49.00M持有股份
$1.63B报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +7.1% ·
股份流向 +7.3% ·
净新建仓位 +6.7%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 140 | -1 | 180.49M | $9.80B | +5 | −5 |
| Q1 2026 | 143 | -1 | 180.18M | $7.73B | +4 | −6 |
| Q4 2025 | 143 | +1 | 192.52M | $8.44B | +2 | — |
| Q3 2025 | 20 | -1 | 116.93M | $4.83B | — | −2 |
| Q2 2025 | 19 | +2 | 115.09M | $5.07B | +2 | — |
| Q1 2025 | 14 | -1 | 52.64M | $1.94B | +1 | −2 |
| Q4 2024 | 15 | +1 | 49.00M | $1.63B | +1 | — |
| Q3 2024 | 13 | 0 | 34.27M | $889.30M | — | — |
| Q2 2024 | 13 | — | 31.74M | $712.85M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 15.30M | -0.4% | $509.35M | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (被动) | 11.41M | — | $380.02M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 5.16M | -0.1% | $171.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 5.16M | -0.1% | $171.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 3.97M | +25.7% | $132.10M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 3.97M | +25.7% | $132.10M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 3.97M | +25.7% | $132.10M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 3.97M | +25.7% | $132.10M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 3.16M | +104.4% | $105.21M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (被动) | 2.85M | +0.8% | $94.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 1.77M | -6.6% | $58.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 1.77M | -6.6% | $58.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 1.62M | +24.7% | $54.00M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 1.62M | +24.7% | $54.00M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 15 | Millennium Management ✦ | 1.34M | +82.3% | $44.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 1.33M | +56.4% | $44.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 427.86K | +41.9% | $14.25M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 18 | Marshall Wace ✦ | 338.28K | -9.7% | $11.26M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 159.66K | -69.3% | $5.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 138.41K | -43.6% | $4.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 138.41K | -43.6% | $4.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 44.83K | 新增 | $1.49M | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Fisher Asset Management | $1.49M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 692 持有人, 256.72M 股份, $10.43B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 10
Beckerle Mary C
Director · 9.81K 股 · $526,512
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13D/A — FARALLON CAPITAL MANAGEMENT, L.L.C.
5.6% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 12
SC 13G/A — AQR CAPITAL MANAGEMENT LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据